Send us a Message



Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   

CHEBI ONTOLOGY - ANNOTATIONS

The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/. The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.

Term:17-ethynyl-17-hydroxy-18a-homoestr-4-en-3-one
go back to main search page
Accession:CHEBI:231594 term browser browse the term
Definition:A 3-oxo-Delta(4) steroid that is gon-4-en-3-one that carries ethyl, hydroxy, and ethynyl groups at positions 13, 17 and 17, respectively.
Synonyms:exact_synonym: 11a-ethyl-1-ethynyl-1-hydroxy-1,2,3,3a,3b,4,5,8,9,9a,9b,10,11,11a-tetradecahydro-7H-cyclopenta[a]phenanthren-7-one
 related_synonym: 13-ethyl-17-ethynyl-17-hydroxy-4-gonen-3-one;   13-ethyl-17-ethynyl-17-hydroxygon-4-en-3-one;   Formula=C21H28O2;   InChI=1S/C21H28O2/c1-3-20-11-9-17-16-8-6-15(22)13-14(16)5-7-18(17)19(20)10-12-21(20,23)4-2/h2,13,16-19,23H,3,5-12H2,1H3;   InChIKey=WWYNJERNGUHSAO-UHFFFAOYSA-N;   SMILES=CCC12CCC3C(CCC4=CC(=O)CCC34)C1CCC2(O)C#C



show annotations for term's descendants           Sort by:
levonorgestrel term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Abcb1a ATP binding cassette subfamily B member 1A increases expression ISO Levonorgestrel results in increased expression of ABCB1 mRNA CTD PMID:15290871 NCBI chr 4:26,312,403...26,488,456
Ensembl chr 4:26,312,409...26,397,135
JBrowse link
G Abhd5 abhydrolase domain containing 5, lysophosphatidic acid acyltransferase multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of ABHD5 mRNA CTD PMID:19074003 NCBI chr 8:130,877,834...130,903,947
Ensembl chr 8:130,877,703...130,903,947
JBrowse link
G Ace2 angiotensin converting enzyme 2 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of ACE2 mRNA CTD PMID:19074003 NCBI chr  X:33,925,458...33,972,851
Ensembl chr  X:33,925,458...33,971,596
JBrowse link
G Adgrf5 adhesion G protein-coupled receptor F5 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in increased expression of ADGRF5 mRNA CTD PMID:19074003 NCBI chr 9:25,014,861...25,128,045
Ensembl chr 9:25,018,277...25,121,237
JBrowse link
G Afg1l AFG1 like ATPase multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in increased expression of AFG1L mRNA CTD PMID:19074003 NCBI chr20:47,380,582...47,550,307
Ensembl chr20:47,380,583...47,550,126
JBrowse link
G Agt angiotensinogen multiple interactions ISO [Ethinyl Estradiol co-treated with Levonorgestrel] results in increased expression of AGT protein CTD PMID:17519148 NCBI chr19:69,426,540...69,447,017
Ensembl chr19:69,421,638...69,446,944
JBrowse link
G Ahctf1 AT hook containing transcription factor 1 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in increased expression of AHCTF1 mRNA CTD PMID:19074003 NCBI chr13:94,013,894...94,068,348
Ensembl chr13:94,014,469...94,068,058
JBrowse link
G Akr1c3 aldo-keto reductase family 1, member C3 decreases activity ISO Levonorgestrel results in decreased activity of AKR1C3 protein CTD PMID:21182831 NCBI chr17:71,020,884...71,037,779
Ensembl chr17:70,970,900...71,048,438
JBrowse link
G Alms1 ALMS1, centrosome and basal body associated protein multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of ALMS1 mRNA CTD PMID:19074003 NCBI chr 4:119,683,085...119,783,471
Ensembl chr 4:119,683,076...119,783,471
JBrowse link
G Alpk2 alpha-kinase 2 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in increased expression of ALPK2 mRNA CTD PMID:19074003 NCBI chr18:61,045,717...61,161,703
Ensembl chr18:61,045,380...61,175,985
JBrowse link
G Alpl alkaline phosphatase, biomineralization associated multiple interactions ISO VDR gene polymorphism affects the reaction [[Ethinyl Estradiol co-treated with Levonorgestrel] affects the expression of ALPL protein] CTD PMID:12521655 NCBI chr 5:155,234,770...155,289,785
Ensembl chr 5:155,234,775...155,254,167
JBrowse link
G Ammecr1 AMMECR nuclear protein 1 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of AMMECR1 mRNA CTD PMID:19074003 NCBI chr  X:111,262,792...111,368,099
Ensembl chr  X:111,262,792...111,368,099
JBrowse link
G Ankdd1a ankyrin repeat and death domain containing 1A multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of ANKDD1A mRNA CTD PMID:19074003 NCBI chr 8:74,912,707...74,938,870
Ensembl chr 8:74,916,011...74,937,863
JBrowse link
G Api5 apoptosis inhibitor 5 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of API5 mRNA CTD PMID:19074003 NCBI chr 3:100,833,417...100,858,580
Ensembl chr 3:100,833,417...100,858,580
JBrowse link
G Apob apolipoprotein B multiple interactions ISO [Ethinyl Estradiol co-treated with Levonorgestrel] results in increased expression of APOB protein CTD PMID:15769986 NCBI chr 6:36,563,704...36,603,300
Ensembl chr 6:36,563,704...36,611,814
JBrowse link
G Ar androgen receptor affects binding
multiple interactions
EXP
ISO
Levonorgestrel binds to AR protein
Levonorgestrel binds to and results in increased activity of AR protein
CTD PMID:14565775 PMID:19833195 PMID:20438827 NCBI chr  X:67,135,317...67,304,476
Ensembl chr  X:67,135,317...67,304,467
JBrowse link
G Arhgap23 Rho GTPase activating protein 23 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in increased expression of ARHGAP23 mRNA CTD PMID:19074003 NCBI chr10:82,891,021...82,993,230
Ensembl chr10:82,890,853...82,993,228
JBrowse link
G Arl9 ARF like GTPase 9 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in increased expression of ARL9 mRNA CTD PMID:19074003 NCBI chr14:31,511,845...31,521,038
Ensembl chr14:31,511,330...31,520,988
JBrowse link
G Asap1 ArfGAP with SH3 domain, ankyrin repeat and PH domain 1 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of ASAP1 mRNA CTD PMID:19074003 NCBI chr 7:97,675,354...97,982,523
Ensembl chr 7:97,675,354...97,982,024
JBrowse link
G Azgp1 alpha-2-glycoprotein 1, zinc-binding multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of AZGP1 mRNA CTD PMID:19074003 NCBI chr12:22,044,685...22,051,248
Ensembl chr12:22,044,751...22,053,020
JBrowse link
G B4galt5 beta-1,4-galactosyltransferase 5 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of B4GALT5 mRNA CTD PMID:19074003 NCBI chr 3:176,437,073...176,453,001
Ensembl chr 3:176,437,073...176,488,978
JBrowse link
G Bbx BBX high mobility group box domain containing multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of BBX mRNA CTD PMID:19074003 NCBI chr11:63,850,034...64,097,700
Ensembl chr11:63,850,018...64,093,265
JBrowse link
G Bcl2 BCL2, apoptosis regulator decreases expression ISO Levonorgestrel results in decreased expression of BCL2 protein CTD PMID:16019350 NCBI chr13:23,204,464...23,366,900
Ensembl chr13:23,204,464...23,366,900
JBrowse link
G Bcl2l14 Bcl2-like 14 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in increased expression of BCL2L14 mRNA CTD PMID:19074003 NCBI chr 4:168,948,919...168,989,450
Ensembl chr 4:168,948,946...168,990,079
JBrowse link
G Bglap bone gamma-carboxyglutamate protein multiple interactions ISO VDR gene polymorphism affects the reaction [[Ethinyl Estradiol co-treated with Levonorgestrel] affects the expression of BGLAP protein] CTD PMID:12521655 NCBI chr 2:176,136,341...176,137,318
Ensembl chr 2:176,136,341...176,137,318
JBrowse link
G Btbd3 BTB domain containing 3 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of BTBD3 mRNA CTD PMID:19074003 NCBI chr 3:146,044,053...146,074,189
Ensembl chr 3:146,044,096...146,074,635
JBrowse link
G C3 complement C3 multiple interactions EXP Levonorgestrel inhibits the reaction [Ethinyl Estradiol results in increased expression of C3 mRNA] CTD PMID:11566438 NCBI chr 9:2,174,412...2,201,339
Ensembl chr 9:2,174,412...2,201,339
JBrowse link
G C4bpb complement component 4 binding protein, beta multiple interactions ISO [Ethinyl Estradiol co-treated with Levonorgestrel] results in decreased expression of C4BPB protein; F5 gene polymorphism inhibits the reaction [[Ethinyl Estradiol co-treated with Levonorgestrel] results in decreased expression of C4BPB protein] CTD PMID:14551147 NCBI chr13:44,673,064...44,683,781
Ensembl chr13:44,673,065...44,683,793
JBrowse link
G Cat catalase multiple interactions ISO [Ethinyl Estradiol co-treated with Levonorgestrel] results in decreased activity of CAT protein CTD PMID:17541152 NCBI chr 3:110,297,340...110,329,526
Ensembl chr 3:110,297,342...110,329,526
JBrowse link
G Ccn3 cellular communication network factor 3 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of CCN3 mRNA CTD PMID:19074003 NCBI chr 7:87,983,788...87,990,810
Ensembl chr 7:87,982,216...87,994,581
JBrowse link
G Cd86 CD86 molecule multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in increased expression of CD86 mRNA CTD PMID:19074003 NCBI chr11:77,647,565...77,706,178
Ensembl chr11:77,647,600...77,725,361
JBrowse link
G Cdc25c cell division cycle 25C multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in increased expression of CDC25C mRNA CTD PMID:19074003 NCBI chr18:26,608,483...26,630,292
Ensembl chr18:26,609,959...26,630,292
JBrowse link
G Cdc42bpb CDC42 binding protein kinase beta multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of CDC42BPB mRNA CTD PMID:19074003 NCBI chr 6:136,154,905...136,241,259
Ensembl chr 6:136,154,905...136,237,570
JBrowse link
G Cdkn2d cyclin dependent kinase inhibitor 2D multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in increased expression of CDKN2D mRNA CTD PMID:19074003 NCBI chr 8:28,108,036...28,110,809
Ensembl chr 8:28,108,044...28,110,809
JBrowse link
G Cep170b centrosomal protein 170B multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of CEP170B mRNA CTD PMID:19074003 NCBI chr 6:137,602,707...137,627,750
Ensembl chr 6:137,602,707...137,627,750
JBrowse link
G Cfap65 cilia and flagella associated protein 65 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in increased expression of CFAP65 mRNA CTD PMID:19074003 NCBI chr 9:83,907,882...83,942,812
Ensembl chr 9:83,907,276...83,942,714
JBrowse link
G Chek2 checkpoint kinase 2 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of CHEK2 mRNA CTD PMID:19074003 NCBI chr12:51,448,838...51,481,159
Ensembl chr12:51,449,140...51,480,667
JBrowse link
G Cimap1a ciliary microtubule associated protein 1A multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in increased expression of CIMAP1A mRNA CTD PMID:19074003 NCBI chr 1:205,355,601...205,358,882
Ensembl chr 1:205,355,675...205,358,882
JBrowse link
G Col1a1 collagen type I alpha 1 chain multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of COL1A1 mRNA CTD PMID:19074003 NCBI chr10:80,380,458...80,397,461
Ensembl chr10:80,380,453...80,397,460
JBrowse link
G Col22a1 collagen type XXII alpha 1 chain multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in increased expression of COL22A1 mRNA CTD PMID:19074003 NCBI chr 7:105,619,776...105,857,246
Ensembl chr 7:105,619,757...105,856,960
JBrowse link
G Cpeb3 cytoplasmic polyadenylation element binding protein 3 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of CPEB3 mRNA CTD PMID:19074003 NCBI chr 1:244,161,690...244,343,765
Ensembl chr 1:244,161,690...244,343,561
JBrowse link
G Cpxcr1 CPX chromosome region, candidate 1 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in increased expression of CPXCR1 mRNA CTD PMID:19074003 NCBI chr  X:85,961,382...85,999,133 JBrowse link
G Crlf3 cytokine receptor-like factor 3 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of CRLF3 mRNA CTD PMID:19074003 NCBI chr10:65,521,296...65,559,162
Ensembl chr10:65,521,492...65,558,804
JBrowse link
G Crp C-reactive protein multiple interactions ISO [Ethinyl Estradiol co-treated with Levonorgestrel] results in increased expression of CRP protein CTD PMID:15769986 NCBI chr13:87,694,062...87,695,978
Ensembl chr13:87,657,317...87,707,514
JBrowse link
G Csmd1 CUB and Sushi multiple domains 1 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in increased expression of CSMD1 mRNA CTD PMID:19074003 NCBI chr16:78,920,549...80,520,710
Ensembl chr16:78,921,002...80,519,944
JBrowse link
G Csnk1a1 casein kinase 1, alpha 1 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of CSNK1A1 mRNA CTD PMID:19074003 NCBI chr18:57,285,156...57,320,540
Ensembl chr18:57,287,412...57,320,538
JBrowse link
G Cxcl10 C-X-C motif chemokine ligand 10 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in increased expression of CXCL10 mRNA CTD PMID:19074003 NCBI chr14:15,989,066...15,991,263
Ensembl chr14:15,989,018...15,991,261
JBrowse link
G Cyp17a1 cytochrome P450, family 17, subfamily a, polypeptide 1 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of CYP17A1 mRNA CTD PMID:19074003 NCBI chr 1:255,476,861...255,484,547
Ensembl chr 1:255,476,861...255,482,974
JBrowse link
G Dap3 death associated protein 3 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of DAP3 mRNA CTD PMID:19074003 NCBI chr 2:176,617,151...176,645,293
Ensembl chr 2:176,617,155...176,644,270
JBrowse link
G Dcn decorin multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in increased expression of DCN mRNA CTD PMID:19074003 NCBI chr 7:34,167,973...34,208,004
Ensembl chr 7:34,163,011...34,218,926
JBrowse link
G Ddhd1 DDHD domain containing 1 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of DDHD1 mRNA CTD PMID:19074003 NCBI chr15:21,304,053...21,370,608
Ensembl chr15:21,303,826...21,370,608
JBrowse link
G Dlgap2 DLG associated protein 2 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in increased expression of DLGAP2 mRNA CTD PMID:19074003 NCBI chr16:81,489,059...82,198,693
Ensembl chr16:81,494,649...82,198,684
JBrowse link
G Dnase1l3 deoxyribonuclease 1L3 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of DNASE1L3 mRNA CTD PMID:19074003 NCBI chr15:19,351,683...19,378,536
Ensembl chr15:19,352,493...19,378,531
JBrowse link
G Dock8 dedicator of cytokinesis 8 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of DOCK8 mRNA CTD PMID:19074003 NCBI chr 1:232,075,468...232,268,830
Ensembl chr 1:232,075,588...232,268,833
JBrowse link
G Dok5 docking protein 5 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in increased expression of DOK5 mRNA CTD PMID:19074003 NCBI chr 3:179,934,419...180,071,334
Ensembl chr 3:179,934,552...180,071,333
JBrowse link
G Dsg1 desmoglein 1 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in increased expression of DSG1 mRNA CTD PMID:19074003 NCBI chr18:11,948,098...11,980,455
Ensembl chr18:11,949,488...11,980,451
JBrowse link
G Elovl5 ELOVL fatty acid elongase 5 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of ELOVL5 mRNA CTD PMID:19074003 NCBI chr 8:87,671,164...87,737,618
Ensembl chr 8:87,671,159...87,737,616
JBrowse link
G Eprs1 glutamyl-prolyl-tRNA synthetase 1 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in increased expression of EPRS1 mRNA CTD PMID:19074003 NCBI chr13:99,431,955...99,503,510
Ensembl chr13:99,433,130...99,503,509
JBrowse link
G Esr1 estrogen receptor 1 multiple interactions ISO Levonorgestrel binds to and results in increased activity of ESR1 protein CTD PMID:33049310 NCBI chr 1:43,511,685...43,904,454
Ensembl chr 1:43,644,392...43,900,354
JBrowse link
G Etnk1 ethanolamine kinase 1 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of ETNK1 mRNA CTD PMID:19074003 NCBI chr 4:177,857,001...177,901,278
Ensembl chr 4:177,856,960...177,924,721
JBrowse link
G Evi2b ecotropic viral integration site 2B multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of EVI2B mRNA CTD PMID:19074003 NCBI chr10:64,970,659...64,972,277
Ensembl chr10:64,964,719...64,979,417
JBrowse link
G F5 coagulation factor V multiple interactions ISO F5 gene polymorphism inhibits the reaction [[Ethinyl Estradiol co-treated with Levonorgestrel] results in decreased expression of C4BPB protein] CTD PMID:14551147 NCBI chr13:79,046,657...79,116,247
Ensembl chr13:79,046,448...79,116,247
JBrowse link
G F7 coagulation factor VII multiple interactions ISO [Ethinyl Estradiol co-treated with Levonorgestrel] results in decreased expression of F7 protein; [Ethinyl Estradiol co-treated with Levonorgestrel] results in increased expression of F7 protein CTD PMID:12618251 PMID:15157790 NCBI chr16:83,191,896...83,202,775
Ensembl chr16:83,191,914...83,202,738
JBrowse link
G F8 coagulation factor VIII multiple interactions ISO [Ethinyl Estradiol co-treated with Levonorgestrel] results in increased expression of F8 protein CTD PMID:12618251 NCBI chr18:155,237...187,186
Ensembl chr18:155,309...186,683
JBrowse link
G Fam20a FAM20A, golgi associated secretory pathway pseudokinase multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in increased expression of FAM20A mRNA CTD PMID:19074003 NCBI chr10:95,136,799...95,197,176
Ensembl chr10:95,142,458...95,197,053
JBrowse link
G Far2 fatty acyl CoA reductase 2 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in increased expression of FAR2 mRNA CTD PMID:19074003 NCBI chr 4:182,705,499...182,819,290
Ensembl chr 4:182,705,381...182,825,279
JBrowse link
G Fcrl5 Fc receptor-like 5 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in increased expression of FCRL5 mRNA CTD PMID:19074003 NCBI chr 2:175,179,630...175,211,180
Ensembl chr 2:175,179,690...175,211,039
JBrowse link
G Fermt2 FERM domain containing kindlin 2 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in increased expression of FERMT2 mRNA CTD PMID:19074003 NCBI chr15:21,162,603...21,257,995
Ensembl chr15:21,162,605...21,258,115
JBrowse link
G Fga fibrinogen alpha chain multiple interactions ISO [Ethinyl Estradiol co-treated with Levonorgestrel] results in increased expression of [FGA protein binds to FGB protein binds to FGG protein] CTD PMID:12618251 PMID:15288212 NCBI chr 2:170,672,169...170,679,572
Ensembl chr 2:170,672,012...170,679,577
JBrowse link
G Fgb fibrinogen beta chain multiple interactions ISO [Ethinyl Estradiol co-treated with Levonorgestrel] results in increased expression of [FGA protein binds to FGB protein binds to FGG protein] CTD PMID:12618251 PMID:15288212 NCBI chr 2:170,693,966...170,700,875
Ensembl chr 2:170,692,965...170,705,434
JBrowse link
G Fgg fibrinogen gamma chain multiple interactions ISO [Ethinyl Estradiol co-treated with Levonorgestrel] results in increased expression of [FGA protein binds to FGB protein binds to FGG protein] CTD PMID:12618251 PMID:15288212 NCBI chr 2:170,652,929...170,660,372
Ensembl chr 2:170,652,234...170,661,170
JBrowse link
G Fkbp6 FKBP prolyl isomerase family member 6 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in increased expression of FKBP6 mRNA CTD PMID:19074003 NCBI chr12:26,947,443...27,026,913
Ensembl chr12:26,947,384...27,026,913
JBrowse link
G Fmnl3 formin-like 3 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of FMNL3 mRNA CTD PMID:19074003 NCBI chr 7:132,333,130...132,384,483
Ensembl chr 7:132,333,130...132,384,483
JBrowse link
G Fnbp1 formin binding protein 1 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of FNBP1 mRNA CTD PMID:19074003 NCBI chr 3:34,706,814...34,826,770
Ensembl chr 3:34,706,814...34,822,117
JBrowse link
G Fshb follicle stimulating hormone subunit beta multiple interactions ISO [Ethinyl Estradiol co-treated with Levonorgestrel] results in decreased expression of FSHB protein; Avosentan affects the reaction [[Ethinyl Estradiol co-treated with Levonorgestrel] affects the expression of FSHB protein] CTD PMID:16291413 PMID:17190377 NCBI chr 3:114,003,262...114,007,072
Ensembl chr 3:114,003,262...114,007,072
JBrowse link
G Gabrg2 gamma-aminobutyric acid type A receptor subunit gamma 2 increases expression EXP Levonorgestrel results in increased expression of GABRG2 protein CTD PMID:22634062 NCBI chr10:26,876,926...26,965,523
Ensembl chr10:26,876,926...26,965,523
JBrowse link
G Gas6 growth arrest specific 6 multiple interactions ISO [Ethinyl Estradiol co-treated with Levonorgestrel] results in decreased expression of GAS6 protein CTD PMID:17717130 NCBI chr16:82,747,676...82,778,090
Ensembl chr16:82,747,345...82,778,088
JBrowse link
G Gdf10 growth differentiation factor 10 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of GDF10 mRNA CTD PMID:19074003 NCBI chr16:9,243,434...9,256,788
Ensembl chr16:9,243,317...9,256,794
JBrowse link
G Gh1 growth hormone 1 multiple interactions ISO [Ethinyl Estradiol co-treated with Levonorgestrel] results in increased expression of GH1 protein CTD PMID:11172797 NCBI chr10:91,727,883...91,729,860
Ensembl chr10:91,727,884...91,729,859
JBrowse link
G Glyr1 glyoxylate reductase 1 homolog multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in increased expression of GLYR1 mRNA CTD PMID:19074003 NCBI chr10:11,038,577...11,074,093
Ensembl chr10:11,038,568...11,074,090
JBrowse link
G Gpr135 G protein-coupled receptor 135 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in increased expression of GPR135 mRNA CTD PMID:19074003 NCBI chr 6:96,363,466...96,366,594
Ensembl chr 6:96,362,867...96,382,988
JBrowse link
G Greb1 growth regulating estrogen receptor binding 1 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of GREB1 mRNA CTD PMID:19074003 NCBI chr 6:45,169,289...45,321,973
Ensembl chr 6:45,169,289...45,291,126
JBrowse link
G Hmmr hyaluronan-mediated motility receptor multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in increased expression of HMMR mRNA CTD PMID:19074003 NCBI chr10:25,635,249...25,665,389
Ensembl chr10:25,635,915...25,665,390
JBrowse link
G Hoxc6 homeo box C6 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in increased expression of HOXC6 mRNA CTD PMID:19074003 NCBI chr 7:136,013,679...136,051,601
Ensembl chr 7:136,024,961...136,027,365
JBrowse link
G Htr7 5-hydroxytryptamine receptor 7 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in increased expression of HTR7 mRNA CTD PMID:19074003 NCBI chr 1:243,049,064...243,173,636
Ensembl chr 1:243,049,081...243,173,230
JBrowse link
G Ice2 interactor of little elongation complex ELL subunit 2 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of ICE2 mRNA CTD PMID:19074003 NCBI chr 8:78,921,962...78,965,983
Ensembl chr 8:78,924,421...78,966,200
JBrowse link
G Igf1 insulin-like growth factor 1 multiple interactions ISO [Ethinyl Estradiol co-treated with Levonorgestrel] results in decreased expression of IGF1 protein CTD PMID:11172797 NCBI chr 7:24,169,608...24,249,446
Ensembl chr 7:24,130,137...24,246,764
JBrowse link
G Igfbp3 insulin-like growth factor binding protein 3 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in increased expression of IGFBP3 mRNA CTD PMID:19074003 NCBI chr14:86,270,208...86,277,944
Ensembl chr14:86,270,208...86,277,944
JBrowse link
G Igsf1 immunoglobulin superfamily, member 1 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of IGSF1 mRNA CTD PMID:19074003 NCBI chr  X:133,947,717...133,963,154
Ensembl chr  X:133,947,429...133,962,962
JBrowse link
G Inha inhibin subunit alpha multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of INHA mRNA CTD PMID:19074003 NCBI chr 9:84,443,109...84,446,010
Ensembl chr 9:84,443,109...84,446,009
JBrowse link
G Insl3 insulin-like 3 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of INSL3 mRNA CTD PMID:19074003 NCBI chr16:18,432,668...18,434,539 JBrowse link
G Insl6 insulin-like 6 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in increased expression of INSL6 mRNA CTD PMID:19074003 NCBI chr 1:236,483,530...236,487,065
Ensembl chr 1:236,483,530...236,487,065
JBrowse link
G Kbtbd7 kelch repeat and BTB domain containing 7 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of KBTBD7 mRNA CTD PMID:19074003 NCBI chr15:61,215,957...61,220,536
Ensembl chr15:61,215,396...61,223,671
JBrowse link
G Kcnh7 potassium voltage-gated channel subfamily H member 7 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in increased expression of KCNH7 mRNA CTD PMID:19074003 NCBI chr 3:67,737,900...68,230,950
Ensembl chr 3:67,747,063...68,230,741
JBrowse link
G Kdsr 3-ketodihydrosphingosine reductase multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of KDSR mRNA CTD PMID:19074003 NCBI chr13:23,374,101...23,408,779
Ensembl chr13:23,376,779...23,408,897
JBrowse link
G Klhl28 kelch-like family member 28 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of KLHL28 mRNA CTD PMID:19074003 NCBI chr 6:88,723,624...88,755,072
Ensembl chr 6:88,727,205...88,752,457
JBrowse link
G Klhl4 kelch-like family member 4 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of KLHL4 mRNA CTD PMID:19074003 NCBI chr  X:83,626,047...83,916,328
Ensembl chr  X:83,819,076...83,916,328
JBrowse link
G Ldlr low density lipoprotein receptor affects expression
multiple interactions
ISO Levonorgestrel affects the expression of LDLR protein
[Levonorgestrel co-treated with Ethinyl Estradiol] results in decreased expression of LDLR protein
CTD PMID:17900441 NCBI chr 8:28,546,191...28,569,075
Ensembl chr 8:28,546,146...28,570,675
JBrowse link
G Lhb luteinizing hormone subunit beta multiple interactions
decreases secretion
ISO [Ethinyl Estradiol co-treated with Levonorgestrel] results in decreased expression of LHB protein; Avosentan affects the reaction [[Ethinyl Estradiol co-treated with Levonorgestrel] affects the expression of LHB protein]
Levonorgestrel results in decreased secretion of LHB protein
CTD PMID:16291413 PMID:17190377 PMID:20599585 NCBI chr 1:105,037,457...105,038,446
Ensembl chr 1:105,037,457...105,038,445
JBrowse link
G Limd1 LIM domain containing 1 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of LIMD1 mRNA CTD PMID:19074003 NCBI chr 8:131,998,262...132,045,924
Ensembl chr 8:131,999,770...132,045,922
JBrowse link
G Lmntd1 lamin tail domain containing 1 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in increased expression of LMNTD1 mRNA CTD PMID:19074003 NCBI chr 4:180,085,128...180,319,362
Ensembl chr 4:180,085,134...180,329,707
JBrowse link
G Lrig2 leucine-rich repeats and immunoglobulin-like domains 2 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of LRIG2 mRNA CTD PMID:19074003 NCBI chr 2:194,635,686...194,705,014
Ensembl chr 2:194,638,182...194,700,940
JBrowse link
G Man2a1 mannosidase, alpha, class 2A, member 1 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of MAN2A1 mRNA CTD PMID:19074003 NCBI chr 9:111,698,913...111,855,257
Ensembl chr 9:111,698,913...111,867,850
JBrowse link
G Mbnl1 muscleblind-like splicing regulator 1 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of MBNL1 mRNA CTD PMID:19074003 NCBI chr 2:146,789,570...146,964,136
Ensembl chr 2:146,789,596...146,964,134
JBrowse link
G Mep1b meprin A subunit beta multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in increased expression of MEP1B mRNA CTD PMID:19074003 NCBI chr18:12,641,041...12,667,759
Ensembl chr18:12,641,041...12,667,755
JBrowse link
G Midn midnolin multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of MIDN mRNA CTD PMID:19074003 NCBI chr 7:10,198,761...10,210,563
Ensembl chr 7:10,200,306...10,207,203
JBrowse link
G Mki67 marker of proliferation Ki-67 decreases expression ISO Levonorgestrel results in decreased expression of MKI67 protein CTD PMID:16019350 NCBI chr 1:199,926,150...199,952,847
Ensembl chr 1:199,926,150...199,952,593
JBrowse link
G Mro maestro multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of MRO mRNA CTD PMID:19074003 NCBI chr18:69,723,764...69,742,815
Ensembl chr18:69,725,798...69,743,031
JBrowse link
G Mrps6 mitochondrial ribosomal protein S6 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of MRPS6 mRNA CTD PMID:19074003 NCBI chr11:44,778,667...44,834,420
Ensembl chr11:44,781,554...44,834,962
JBrowse link
G Mtss1 MTSS I-BAR domain containing 1 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in increased expression of MTSS1 mRNA CTD PMID:19074003 NCBI chr 7:92,378,228...92,517,444
Ensembl chr 7:92,378,238...92,517,303
JBrowse link
G Mysm1 myb-like, SWIRM and MPN domains 1 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of MYSM1 mRNA CTD PMID:19074003 NCBI chr 5:114,877,112...114,981,463
Ensembl chr 5:114,889,269...114,942,385
JBrowse link
G Nacc2 NACC family member 2 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of NACC2 mRNA CTD PMID:19074003 NCBI chr 3:29,278,077...29,345,098
Ensembl chr 3:29,281,190...29,344,840
JBrowse link
G Ndfip1 Nedd4 family interacting protein 1 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of NDFIP1 mRNA CTD PMID:19074003 NCBI chr18:30,516,931...30,567,199
Ensembl chr18:30,516,981...30,568,471
JBrowse link
G Nexn nexilin (F actin binding protein) multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of NEXN mRNA CTD PMID:19074003 NCBI chr 2:243,846,736...243,878,268
Ensembl chr 2:243,846,433...243,887,114
JBrowse link
G Nid1 nidogen 1 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of NID1 mRNA CTD PMID:19074003 NCBI chr17:93,069,013...93,142,416
Ensembl chr17:93,069,278...93,142,386
JBrowse link
G Nr1i2 nuclear receptor subfamily 1, group I, member 2 multiple interactions ISO Levonorgestrel binds to and results in increased activity of NR1I2 protein CTD PMID:33049310 NCBI chr11:75,965,717...76,006,733
Ensembl chr11:75,965,632...76,002,380
JBrowse link
G Nsg1 neuronal vesicle trafficking associated 1 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of NSG1 mRNA CTD PMID:19074003 NCBI chr14:76,861,079...76,882,822
Ensembl chr14:76,860,746...76,883,390
JBrowse link
G Olfml3 olfactomedin-like 3 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of OLFML3 mRNA CTD PMID:19074003 NCBI chr 2:193,932,665...193,935,494
Ensembl chr 2:193,932,665...193,935,494
JBrowse link
G Opn5 opsin 5 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in increased expression of OPN5 mRNA CTD PMID:19074003 NCBI chr 9:25,865,610...25,913,315
Ensembl chr 9:25,865,610...25,913,315
JBrowse link
G Or10j2 olfactory receptor family 10 subfamily J member 2 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in increased expression of OR10J1 mRNA CTD PMID:19074003 NCBI chr13:88,255,644...88,256,634
Ensembl chr13:88,255,644...88,256,634
JBrowse link
G Osbpl10 oxysterol binding protein-like 10 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in increased expression of OSBPL10 mRNA CTD PMID:19074003 NCBI chr 8:123,536,818...123,796,822
Ensembl chr 8:123,539,235...123,796,822
JBrowse link
G Pak3 p21 (RAC1) activated kinase 3 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of PAK3 mRNA CTD PMID:19074003 NCBI chr  X:111,912,967...112,171,037
Ensembl chr  X:111,913,059...112,165,035
JBrowse link
G Pappa pappalysin multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of PAPPA mRNA CTD PMID:19074003 NCBI chr 5:83,513,358...83,751,364
Ensembl chr 5:83,513,358...83,751,361
JBrowse link
G Pard6b par-6 family cell polarity regulator beta multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of PARD6B mRNA CTD PMID:19074003 NCBI chr 3:177,209,429...177,230,509
Ensembl chr 3:177,209,258...177,230,510
JBrowse link
G Pcdh7 protocadherin 7 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of PCDH7 mRNA CTD PMID:19074003 NCBI chr14:56,684,817...57,114,976
Ensembl chr14:56,687,725...57,112,665
JBrowse link
G Pde1c phosphodiesterase 1C multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in increased expression of PDE1C mRNA CTD PMID:19074003 NCBI chr 4:86,629,074...87,108,147
Ensembl chr 4:86,626,282...87,193,259
JBrowse link
G Pgr progesterone receptor multiple interactions ISO Levonorgestrel binds to and results in increased activity of PGR protein CTD PMID:20599585 NCBI chr 8:14,354,398...14,413,271
Ensembl chr 8:14,354,398...14,413,271
JBrowse link
G Pkp4 plakophilin 4 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of PKP4 mRNA CTD PMID:19074003 NCBI chr 3:64,040,995...64,244,586
Ensembl chr 3:64,141,771...64,244,586
JBrowse link
G Plagl1 PLAG1 like zinc finger 1 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of PLAGL1 mRNA CTD PMID:19074003 NCBI chr 1:9,297,066...9,337,394
Ensembl chr 1:9,330,204...9,337,394
JBrowse link
G Plat plasminogen activator, tissue type multiple interactions ISO [Ethinyl Estradiol co-treated with Levonorgestrel] results in decreased expression of PLAT protein; [Ethinyl Estradiol co-treated with Levonorgestrel] results in increased activity of PLAT protein CTD PMID:12618251 PMID:15157790 PMID:15288212 NCBI chr16:75,943,061...76,022,037
Ensembl chr16:75,943,064...75,967,696
JBrowse link
G Plg plasminogen multiple interactions ISO [Ethinyl Estradiol co-treated with Levonorgestrel] results in increased expression of PLG protein CTD PMID:12618251 PMID:15157790 NCBI chr 1:50,872,927...50,915,406
Ensembl chr 1:50,872,926...50,917,320
JBrowse link
G Poglut1 protein O-glucosyltransferase 1 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of POGLUT1 mRNA CTD PMID:19074003 NCBI chr11:75,704,119...75,731,964
Ensembl chr11:75,703,833...75,733,519
JBrowse link
G Pon1 paraoxonase 1 multiple interactions ISO [Ethinyl Estradiol co-treated with Levonorgestrel] affects the activity of PON1 protein CTD PMID:17541152 NCBI chr 4:34,261,312...34,292,327
Ensembl chr 4:34,261,289...34,287,924
JBrowse link
G Ppp2r2c protein phosphatase 2, regulatory subunit B, gamma multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in increased expression of PPP2R2C mRNA CTD PMID:19074003 NCBI chr14:78,071,274...78,156,212
Ensembl chr14:78,071,274...78,156,212
JBrowse link
G Prkab1 protein kinase AMP-activated non-catalytic subunit beta 1 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in increased expression of PRKAB1 mRNA CTD PMID:19074003 NCBI chr12:46,248,971...46,259,487
Ensembl chr12:46,249,010...46,259,482
JBrowse link
G Proc protein C, inactivator of coagulation factors Va and VIIIa multiple interactions ISO [Ethinyl Estradiol co-treated with Levonorgestrel] results in increased activity of PROC protein; [Ethinyl Estradiol co-treated with Levonorgestrel] results in increased expression of PROC protein CTD PMID:12618251 PMID:14551147 PMID:15288212 NCBI chr18:24,038,596...24,049,061
Ensembl chr18:24,038,597...24,048,964
JBrowse link
G Pros1 protein S multiple interactions ISO [Ethinyl Estradiol co-treated with Levonorgestrel] results in decreased activity of PROS1 protein; [Ethinyl Estradiol co-treated with Levonorgestrel] results in decreased expression of PROS1 protein CTD PMID:12618251 PMID:14551147 NCBI chr11:13,676,310...13,757,858
Ensembl chr11:13,676,769...13,757,852
JBrowse link
G Ptbp2 polypyrimidine tract binding protein 2 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of PTBP2 mRNA CTD PMID:19074003 NCBI chr 2:210,497,610...210,558,497
Ensembl chr 2:210,497,706...210,558,291
JBrowse link
G Ptger2 prostaglandin E receptor 2 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of PTGER2 mRNA CTD PMID:19074003 NCBI chr15:20,694,765...20,708,475
Ensembl chr15:20,696,013...20,708,950
JBrowse link
G Ptges prostaglandin E synthase multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of PTGES mRNA CTD PMID:19074003 NCBI chr 3:34,575,643...34,586,987
Ensembl chr 3:34,575,639...34,586,995
JBrowse link
G Rab11fip3 RAB11 family interacting protein 3 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of RAB11FIP3 mRNA CTD PMID:19074003 NCBI chr10:15,507,151...15,591,173
Ensembl chr10:15,507,151...15,591,173
JBrowse link
G Rab1a RAB1A, member RAS oncogene family multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in increased expression of RAB1A mRNA CTD PMID:19074003 NCBI chr14:98,623,582...98,648,766
Ensembl chr14:98,623,635...98,661,582
JBrowse link
G Rapgef6 Rap guanine nucleotide exchange factor 6 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of RAPGEF6 mRNA CTD PMID:19074003 NCBI chr10:39,156,573...39,324,947
Ensembl chr10:39,156,620...39,324,946
JBrowse link
G Recql RecQ like helicase multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of RECQL mRNA CTD PMID:19074003 NCBI chr 4:177,039,351...177,063,968
Ensembl chr 4:177,035,128...177,063,838
JBrowse link
G Rftn2 raftlin family member 2 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in increased expression of RFTN2 mRNA CTD PMID:19074003 NCBI chr 9:64,146,062...64,202,342
Ensembl chr 9:64,124,865...64,215,186
JBrowse link
G Rln1 relaxin 1 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in increased expression of RLN1 mRNA CTD PMID:19074003 NCBI chr 1:236,493,532...236,496,541
Ensembl chr 1:236,493,536...236,496,440
JBrowse link
G Rnf216 ring finger protein 216 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in increased expression of RNF216 mRNA CTD PMID:19074003 NCBI chr12:16,568,327...16,689,868
Ensembl chr12:16,568,347...16,690,989
JBrowse link
G Rnft1 ring finger protein, transmembrane 1 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in increased expression of RNFT1 mRNA CTD PMID:19074003 NCBI chr10:71,807,403...71,821,132
Ensembl chr10:71,807,456...71,821,141
JBrowse link
G RT1-Bb RT1 class II, locus Bb multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in increased expression of HLA-DQB1 mRNA CTD PMID:19074003 NCBI chr20:4,598,475...4,604,118
Ensembl chr20:4,598,475...4,604,118
JBrowse link
G Saraf store-operated calcium entry-associated regulatory factor multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in increased expression of SARAF mRNA CTD PMID:19074003 NCBI chr16:64,720,404...64,738,653
Ensembl chr16:64,720,418...64,738,653
JBrowse link
G Scaf4 SR-related CTD-associated factor 4 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of SCAF4 mRNA CTD PMID:19074003 NCBI chr11:42,951,254...43,007,293
Ensembl chr11:42,951,254...43,007,293
JBrowse link
G Senp1 SUMO specific peptidase 1 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in increased expression of SENP1 mRNA CTD PMID:19074003 NCBI chr 7:131,042,237...131,105,826
Ensembl chr 7:131,044,818...131,100,851
JBrowse link
G Serpina5 serpin family A member 5 multiple interactions ISO [Ethinyl Estradiol co-treated with Levonorgestrel] results in increased expression of SERPINA5 protein CTD PMID:14551147 NCBI chr 6:128,774,006...128,793,187
Ensembl chr 6:128,784,991...128,793,186
JBrowse link
G Serpinb3 serpin family B member 3 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in increased expression of SERPINB3 mRNA CTD PMID:19074003 NCBI chr13:23,788,758...23,795,298
Ensembl chr13:23,788,758...23,795,298
JBrowse link
G Serpinc1 serpin family C member 1 multiple interactions ISO [Ethinyl Estradiol co-treated with Levonorgestrel] results in decreased activity of SERPINC1 protein; [Ethinyl Estradiol co-treated with Levonorgestrel] results in decreased expression of SERPINC1 protein CTD PMID:12618251 PMID:14981370 PMID:15288212 NCBI chr13:75,790,558...75,804,826
Ensembl chr13:75,790,546...75,817,643
JBrowse link
G Serpine1 serpin family E member 1 multiple interactions ISO [Ethinyl Estradiol co-treated with Levonorgestrel] results in decreased activity of SERPINE1 protein; [Ethinyl Estradiol co-treated with Levonorgestrel] results in decreased expression of SERPINE1 protein CTD PMID:14981370 PMID:15157790 PMID:15288212 NCBI chr12:25,237,977...25,248,356
Ensembl chr12:25,237,952...25,248,357
JBrowse link
G Sfrp5 secreted frizzled-related protein 5 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in increased expression of SFRP5 mRNA CTD PMID:19074003 NCBI chr 1:250,956,050...250,960,512
Ensembl chr 1:250,956,050...250,960,512
JBrowse link
G Shbg sex hormone binding globulin affects binding
multiple interactions
ISO Levonorgestrel binds to SHBG protein
[Ethinyl Estradiol co-treated with Levonorgestrel] results in increased expression of SHBG protein
CTD PMID:12586319 PMID:14981370 PMID:17519148 NCBI chr10:54,831,716...54,849,162
Ensembl chr10:54,831,718...54,838,760
JBrowse link
G Skic3 SKI3 subunit of superkiller complex multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of SKIC3 mRNA CTD PMID:19074003 NCBI chr 2:7,363,417...7,526,351
Ensembl chr 2:7,363,535...7,483,496
JBrowse link
G Slc16a9 solute carrier family 16, member 9 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of SLC16A9 mRNA CTD PMID:19074003 NCBI chr20:18,334,946...18,376,195
Ensembl chr20:18,334,946...18,376,195
JBrowse link
G Slc25a2 solute carrier family 25 member 2 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in increased expression of SLC25A2 mRNA CTD PMID:19074003 NCBI chr18:29,704,182...29,707,563
Ensembl chr18:29,703,871...29,708,827
JBrowse link
G Slc2a5 solute carrier family 2 member 5 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in increased expression of SLC2A5 mRNA CTD PMID:19074003 NCBI chr 5:165,857,412...165,892,928
Ensembl chr 5:165,866,172...165,894,038
JBrowse link
G Smyd2 SET and MYND domain containing 2 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of SMYD2 mRNA CTD PMID:19074003 NCBI chr13:103,956,470...103,997,774
Ensembl chr13:103,956,473...103,997,774
JBrowse link
G Snrpn small nuclear ribonucleoprotein polypeptide N multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of SNRPN mRNA CTD PMID:19074003 NCBI chr 1:120,316,846...120,338,919
Ensembl chr 1:120,315,556...120,323,924
JBrowse link
G Sobp sine oculis binding protein homolog multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in increased expression of SOBP mRNA CTD PMID:19074003 NCBI chr20:48,064,445...48,243,607
Ensembl chr20:48,064,445...48,243,607
JBrowse link
G Spin4 spindlin family, member 4 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of SPIN4 mRNA CTD PMID:19074003 NCBI chr  X:63,898,338...63,902,427
Ensembl chr  X:63,900,148...63,903,811
JBrowse link
G Sptbn1 spectrin, beta, non-erythrocytic 1 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of SPTBN1 mRNA CTD PMID:19074003 NCBI chr14:108,042,629...108,217,884
Ensembl chr14:108,042,629...108,217,836
JBrowse link
G Srgn serglycin multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of SRGN mRNA CTD PMID:19074003 NCBI chr20:30,985,508...31,022,296
Ensembl chr20:30,985,508...31,000,327
JBrowse link
G Stxbp5l syntaxin binding protein 5L multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in increased expression of STXBP5L mRNA CTD PMID:19074003 NCBI chr11:76,838,839...77,167,852
Ensembl chr11:76,838,900...77,161,306
JBrowse link
G Syt11 synaptotagmin 11 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of SYT11 mRNA CTD PMID:19074003 NCBI chr 2:176,503,845...176,530,354
Ensembl chr 2:176,503,845...176,529,775
JBrowse link
G Thrb thyroid hormone receptor beta multiple interactions ISO Levonorgestrel binds to and results in increased activity of THRB protein CTD PMID:33049310 NCBI chr15:10,115,954...10,465,231
Ensembl chr15:10,115,954...10,313,680
JBrowse link
G Tmem217 transmembrane protein 217 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in increased expression of TMEM217 mRNA CTD PMID:19074003 NCBI chr20:7,594,223...7,620,628
Ensembl chr20:7,594,405...7,620,558
JBrowse link
G Tmem225 transmembrane protein 225 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in increased expression of TMEM225 mRNA CTD PMID:19074003 NCBI chr 8:49,394,638...49,397,196
Ensembl chr 8:49,394,504...49,397,485
JBrowse link
G Tmem35a transmembrane protein 35A multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of TMEM35A mRNA CTD PMID:19074003 NCBI chr  X:101,796,623...101,807,471
Ensembl chr  X:101,796,623...101,807,470
JBrowse link
G Tmod2 tropomodulin 2 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of TMOD2 mRNA CTD PMID:19074003 NCBI chr 8:85,197,222...85,250,627
Ensembl chr 8:85,196,226...85,246,371
JBrowse link
G Tnf tumor necrosis factor multiple interactions ISO [Ethinyl Estradiol co-treated with Levonorgestrel] results in increased expression of TNF protein CTD PMID:15769986 NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,626,532...3,629,303
JBrowse link
G Tnfrsf11b TNF receptor superfamily member 11B increases expression ISO Levonorgestrel results in increased expression of TNFRSF11B mRNA CTD PMID:16114553 NCBI chr 7:87,456,318...87,484,324
Ensembl chr 7:87,456,319...87,485,075
JBrowse link
G Tnfsf11 TNF superfamily member 11 decreases expression ISO Levonorgestrel results in decreased expression of TNFSF11 mRNA CTD PMID:16114553 NCBI chr15:60,083,008...60,114,479
Ensembl chr15:60,083,008...60,114,479
JBrowse link
G Tnrc6b trinucleotide repeat containing adaptor 6B multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of TNRC6B mRNA CTD PMID:19074003 NCBI chr 7:114,132,574...114,350,010
Ensembl chr 7:114,132,573...114,342,973
JBrowse link
G Tra2a transformer 2 alpha multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of TRA2A mRNA CTD PMID:19074003 NCBI chr 4:79,551,699...79,570,621
Ensembl chr 4:79,551,542...79,570,619
JBrowse link
G Trmt13 tRNA methyltransferase 13 homolog multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of TRMT13 mRNA CTD PMID:19074003 NCBI chr 2:207,217,399...207,232,467
Ensembl chr 2:207,218,552...207,231,701
JBrowse link
G Ubap1 ubiquitin-associated protein 1 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of UBAP1 mRNA CTD PMID:19074003 NCBI chr 5:61,316,650...61,357,077
Ensembl chr 5:61,316,643...61,357,076
JBrowse link
G Ube2d3 ubiquitin-conjugating enzyme E2D 3 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of UBE2D3 mRNA CTD PMID:19074003 NCBI chr 2:226,543,194...226,571,001
Ensembl chr 2:226,540,531...226,573,144
JBrowse link
G Vcam1 vascular cell adhesion molecule 1 multiple interactions ISO [Ethinyl Estradiol co-treated with Levonorgestrel] results in decreased expression of VCAM1 protein CTD PMID:15769986 NCBI chr 2:206,723,050...206,742,783
Ensembl chr 2:206,723,044...206,742,801
JBrowse link
G Vdr vitamin D receptor multiple interactions ISO VDR gene polymorphism affects the reaction [[Ethinyl Estradiol co-treated with Levonorgestrel] affects the expression of ALPL protein]; VDR gene polymorphism affects the reaction [[Ethinyl Estradiol co-treated with Levonorgestrel] affects the expression of BGLAP protein] CTD PMID:12521655 NCBI chr 7:130,864,764...130,916,757
Ensembl chr 7:130,866,745...130,916,757
JBrowse link
G Vegfa vascular endothelial growth factor A increases expression ISO Levonorgestrel results in increased expression of VEGFA mRNA; Levonorgestrel results in increased expression of VEGFA mRNA alternative form CTD PMID:17010073 NCBI chr 9:22,452,854...22,468,194
Ensembl chr 9:22,439,392...22,468,194
JBrowse link
G Xylt1 xylosyltransferase 1 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of XYLT1 mRNA CTD PMID:19074003 NCBI chr 1:181,078,222...181,361,047
Ensembl chr 1:181,078,222...181,361,047
JBrowse link
G Yeats2 YEATS domain containing 2 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of YEATS2 mRNA CTD PMID:19074003 NCBI chr11:94,247,538...94,333,652
Ensembl chr11:94,247,538...94,333,292
JBrowse link
G Zcchc7 zinc finger CCHC-type containing 7 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of ZCCHC7 mRNA CTD PMID:19074003 NCBI chr 5:63,787,292...63,968,960
Ensembl chr 5:63,788,217...63,968,549
JBrowse link
G Zeb2 zinc finger E-box binding homeobox 2 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of ZEB2 mRNA CTD PMID:19074003 NCBI chr 3:49,624,028...49,754,323
Ensembl chr 3:49,624,028...49,754,323
JBrowse link
G Zfand6 zinc finger AN1-type containing 6 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of ZFAND6 mRNA CTD PMID:19074003 NCBI chr 1:147,990,099...148,061,221
Ensembl chr 1:147,990,108...148,061,134
JBrowse link
G Zfp518a zinc finger protein 518A multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of ZNF518A mRNA CTD PMID:19074003 NCBI chr 1:249,668,815...249,694,401
Ensembl chr 1:249,657,809...249,695,569
JBrowse link
G Zfp638 zinc finger protein 638 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of ZNF638 mRNA CTD PMID:19074003 NCBI chr 4:117,913,528...118,032,644
Ensembl chr 4:117,913,545...118,032,643
JBrowse link
G Zfr zinc finger RNA binding protein multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of ZFR mRNA CTD PMID:19074003 NCBI chr 2:62,864,333...62,927,377
Ensembl chr 2:62,864,338...62,929,133
JBrowse link
G Zkscan7 zinc finger with KRAB and SCAN domains 7 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in increased expression of ZKSCAN7 mRNA CTD PMID:19074003 NCBI chr 8:131,379,514...131,397,065
Ensembl chr 8:131,378,013...131,397,065
JBrowse link
norgestrel term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Adipoq adiponectin, C1Q and collagen domain containing multiple interactions ISO Norgestrel inhibits the reaction [[Dexamethasone co-treated with Rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of and results in increased secretion of ADIPOQ protein] CTD PMID:29782964 NCBI chr11:91,226,524...91,240,244
Ensembl chr11:91,226,180...91,240,169
JBrowse link
G Ar androgen receptor multiple interactions ISO 1-hydroxypyrene inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; 17 alpha-Hydroxyprogesterone Caproate inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; 17-alpha-Hydroxyprogesterone inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; 2,2',4,4'-tetrahydroxybenzophenone inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; 2,2'-bisphenol F inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; 2,2'-dihydroxy-6,6'-dinaphthyldisulfide inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; 2,2-bis(4-hydroxyphenyl)-1,1,1-trichloroethane inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; 2,4,6-triiodophenol inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; 2,5-di-tert-butylhydroquinone inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; 2-chloro-4-phenylphenol inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; 2-tert-butylhydroquinone inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; 2-tolidine inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; 3-iodo-2-propynylbutylcarbamate inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; 3-phenoxybenzylalcohol inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; 4,4'-dichlorodiphenyl sulfone inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; 4-cumylphenol inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; 4-phenylphenol inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; 4-tert-octylphenol inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; 7-dimethylamino-4-methylcoumarin inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; 9,10-Dimethyl-1,2-benzanthracene inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; 9-phenanthrol inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; [6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein; acetochlor inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; acetyl methyl tetramethyl tetralin inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; afimoxifene inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; alpha-isomethylionone inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; Apigenin inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; atraric acid inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; Azinphosmethyl inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; bicalutamide inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; bisphenol A inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; bisphenol AF inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; bromadiolone inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; bromuconazole inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; butylbenzyl phthalate inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; butylphen inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; Chlordecone inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; chlorobenzilate inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; chloroxylenol inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; Clomiphene inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; clorophene inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; Coumaphos inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; Cyproterone Acetate inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; d,d-T80-prallethrin inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; DDT inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; Dehydroepiandrosterone inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; devrinol inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; di-n-pentyl phthalate inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; diallyl phthalate inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; Dibutyl Phthalate inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; Dichlorodiphenyl Dichloroethylene inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; Dichlorodiphenyldichloroethane inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; dicloran inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; dimethomorph inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; diniconazole inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; Disulfiram inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; dithiopyr inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; Diuron inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; Endosulfan inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; enilconazole inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; Equilin inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; Estrone inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; ethafluralin inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; Ethinyl Estradiol inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; fenamiphos inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; fenarimol inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; Fenitrothion inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; Fenthion inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; Finasteride inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; fludioxonil inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; flumetralin inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; fluoranthene inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; Flutamide inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; Genistein inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; Hexestrol inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; hydroxyflutamide inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; iprodione inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; Linuron inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; Melengestrol Acetate inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; Mestranol inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; metconazole inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; Methoxychlor inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; Methyl Parathion inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; metolachlor inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; Mitotane inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; N-(2-ethylhexyl)-5-norbornene-2,3-dicarboxamide inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; nilutamide inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; nitrofen inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; nonylphenol inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; Norgestrel binds to and results in increased activity of AR protein; o,p'-DDT inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; oryzalin inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; oxybenzone inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; p-tert-amylphenol inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; pendimethalin inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; phenanthrene inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; phenothiazine inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; phosalone inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; phoxim inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; prochloraz inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; procymidone inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; pronamide inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; Propanil inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; propiconazole inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; propylparaben inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; pyrene inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; S-methyl benzo(1,2,3)thiadiazole-7-carbothioate inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; Spironolactone inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; tebuconazole inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; Testosterone Propionate inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; tetrabromobisphenol A inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; tetrachlorodian inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; Tetrachlorvinphos inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; tri-(2-ethylhexyl)trimellitate inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; tributyltin inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; Triclosan inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; triflumizol inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; Trifluralin inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; Triiodothyronine inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; triphenyl phosphate inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; triphenyltin chloride inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; tris(1,3-dichloro-2-propyl)phosphate inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; triticonazole inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; Troglitazone inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; vinclozolin inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein] CTD PMID:33049310 NCBI chr  X:67,135,317...67,304,476
Ensembl chr  X:67,135,317...67,304,467
JBrowse link
G Esr1 estrogen receptor 1 increases activity
multiple interactions
EXP
ISO
Norgestrel results in increased activity of ESR1 protein
Norgestrel binds to and results in increased activity of ESR1 protein
CTD PMID:11750080 PMID:12504345 PMID:33049310 NCBI chr 1:43,511,685...43,904,454
Ensembl chr 1:43,644,392...43,900,354
JBrowse link
G Fabp4 fatty acid binding protein 4 multiple interactions ISO [Norgestrel co-treated with Rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of FABP4 protein; Norgestrel inhibits the reaction [[Dexamethasone co-treated with Rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of FABP4 protein] CTD PMID:29782964 NCBI chr 2:93,488,251...93,492,961
Ensembl chr 2:93,488,271...93,492,972
JBrowse link
G Ins2 insulin 2 multiple interactions ISO [Norgestrel co-treated with Rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of FABP4 protein; Norgestrel inhibits the reaction [[Dexamethasone co-treated with Rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of and results in increased secretion of ADIPOQ protein]; Norgestrel inhibits the reaction [[Dexamethasone co-treated with Rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of FABP4 protein] CTD PMID:29782964 NCBI chr 1:207,272,738...207,421,998
Ensembl chr 1:207,272,742...207,273,805
JBrowse link
G Klk1c10 kallikrein 1-related peptidase C10 increases expression ISO Norgestrel results in increased expression of KLK3 protein CTD PMID:11580929 NCBI chr 1:103,539,527...103,543,586
Ensembl chr 1:103,539,527...103,543,586
JBrowse link
G Nr1i2 nuclear receptor subfamily 1, group I, member 2 multiple interactions ISO Norgestrel binds to and results in increased activity of NR1I2 protein CTD PMID:33049310 NCBI chr11:75,965,717...76,006,733
Ensembl chr11:75,965,632...76,002,380
JBrowse link

Term paths to the root
Path 1
Term Annotations click to browse term
  CHEBI ontology 20871
    chemical entity 20869
      group 20813
        organic group 19543
          3-oxo-Delta(4)-steroid group 9254
            3-oxo-Delta(4) steroid 9254
              17-ethynyl-17-hydroxy-18a-homoestr-4-en-3-one 199
                dextronorgestrel + 7
                levonorgestrel + 199
Path 2
Term Annotations click to browse term
  CHEBI ontology 20871
    subatomic particle 20869
      composite particle 20869
        hadron 20869
          baryon 20869
            nucleon 20869
              atomic nucleus 20869
                atom 20869
                  main group element atom 20792
                    p-block element atom 20792
                      carbon group element atom 20725
                        carbon atom 20721
                          organic molecular entity 20721
                            heteroorganic entity 20226
                              organochalcogen compound 19911
                                organooxygen compound 19814
                                  carbonyl compound 19446
                                    ketone 17462
                                      oxo steroid 10641
                                        3-oxo steroid 10018
                                          3-oxo-Delta(4) steroid 9254
                                            17-ethynyl-17-hydroxy-18a-homoestr-4-en-3-one 199
                                              dextronorgestrel + 7
                                              levonorgestrel + 199
paths to the root